Market By Device Type And Country | Forecast 2021-2028
As per Triton’s report, the Middle East and Africa market for peripheral vascular devices is expected to surge with a CAGR of 10.51% over the forecast years from 2021 to 2028.
The countries reviewed in this market are:
•          Saudi Arabia
•          South Africa
•          Turkey
•          The United Arab Emirates
•          Rest of MEA countries
Cholesterol is a common health problem among Turks. Also, physical inactivity is reported in both genders, and smoking and obesity are also common. This has led to a high prevalence of diseases like hypertension and diabetes in them. There is a growing burden of non-communicable diseases being faced by 80 million inhabitants in the country. It is estimated that around 86% of total deaths are caused by NCDs, and almost 1 in 5 adults dies prematurely. CVDs account for nearly half (47%) of all deaths. By the year 2030, CVD mortality is projected to increase by 2.3 times in men and 1.8 times in women.
The Turkish health ministry has prioritized CVD prevention, and multiple regulatory efforts are being taken to promote healthy lifestyle habits. The nation has set up a national-level non-communicable diseases policy and action plan to collect reliable mortality data and risk-factor surveys. All these factors are expected to influence people to seek treatment for such diseases, which, in turn, will increase the adoption of peripheral vascular devices. This will boost the growth of the market studied in the forthcoming years.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. KEY INSIGHTSÂ Â Â Â Â Â
2.1.1.  SURGE IN THE ADOPTION OF VASCULAR PROCEDURES        Â
2.1.2.  PRODUCT RECALLS OWING TO THE SAFETY CONCERN          Â
2.2. IMPACT OF COVID-19 ON THE PERIPHERAL VASCULAR DEVICES MARKETÂ Â Â Â Â Â Â Â Â Â
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1.  THREAT OF NEW ENTRANTS  Â
2.3.2.  THREAT OF SUBSTITUTE          Â
2.3.3.  BARGAINING POWER OF SUPPLIERS
2.3.4.  BARGAINING POWER OF BUYERS    Â
2.3.5.  THREAT OF COMPETITIVE RIVALRY Â
2.4. MARKET ATTRACTIVENESS INDEXÂ Â
2.5. VENDOR SCORECARDÂ
2.6. KEY MARKET STRATEGIESÂ Â Â Â Â
2.6.1.  MERGER & ACQUISITIONS       Â
2.6.2.  PRODUCT LAUNCH & DEVELOPMENTS       Â
2.6.3.  PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATIONÂ
2.6.4.  BUSINESS EXPANSION Â
2.7. MARKET DRIVERSÂ Â Â Â Â Â Â Â Â
2.7.1.  MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE  Â
2.7.2.  PROLIFERATING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE  Â
2.7.3.  CHANGING LIFESTYLE AND RAPID GROWTH IN THE AGING POPULATION Â
2.7.4.  CONTINUOUS TECHNOLOGICAL ADVANCEMENTS         Â
2.8. MARKET CHALLENGES
2.8.1.  STRINGENT REGULATORY PROCESS         Â
2.8.2.  LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES        Â
2.8.3.  INTENSE COMPETITIONÂ
2.9. MARKET OPPORTUNITIESÂ Â Â Â Â Â Â
2.9.1.  AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS        Â
2.9.2.  MARKET POTENTIAL IN DEVELOPING COUNTRIES         Â
3.   MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET OUTLOOK – BY DEVICE TYPE  Â
3.1. PERIPHERAL VASCULAR STENTSÂ Â Â Â
3.1.1.  SELF-EXPANDING PERIPHERAL VASCULAR STENTS     Â
3.1.2.  BALLOON-EXPANDING PERIPHERAL VASCULAR STENTS        Â
3.1.3.  DRUG ELUTING PERIPHERAL VASCULAR STENTS         Â
3.1.4.  COVERED STENTÂ
3.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ
3.2.1.  STANDARD PTA BALLOON CATHETER        Â
3.2.2.  HIGH-PRESSURE PTA BALLOON CATHETER         Â
3.2.3.  LARGE PTA BALLOON CATHETER     Â
3.2.4.  SMALL PTA BALLOON CATHETER     Â
3.2.5.  SPECIALTY PTA BALLOON CATHETER        Â
3.2.6.  DRUG COATED PTA BALLOON CATHETER Â
3.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRESÂ Â Â Â Â Â Â Â
3.4. ATHERECTOMY DEVICESÂ Â Â Â Â Â Â Â
3.5. EMBOLIC PROTECTION DEVICESÂ Â Â Â Â
3.6. INFERIOR VENA CAVA FILTERSÂ Â Â Â Â Â Â Â Â
3.7. OTHER DEVICE TYPESÂ
4.   MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET – COUNTRY OUTLOOK                     Â
4.1. UNITED ARAB EMIRATESÂ Â Â Â Â Â Â Â Â
4.2. TURKEYÂ Â Â Â Â
4.3. SAUDI ARABIAÂ Â Â Â Â
4.4. SOUTH AFRICAÂ Â Â
4.5. REST OF MIDDLE EAST & AFRICAÂ Â Â Â
5.   COMPETITIVE LANDSCAPE
5.1. ABBOTT LABORATORIESÂ Â Â Â Â Â Â Â Â
5.2. ANGIOSCORE INC (SPECTRANETICS CORPORATION)Â Â
5.3. BOSTON SCIENTIFIC CORPORATIONÂ Â Â Â Â Â Â Â Â Â
5.4. BECTON DICKINSON AND COMPANYÂ Â Â Â Â Â Â Â Â Â
5.5. COOK GROUPÂ Â Â Â Â Â
5.6. CARDINAL HEALTH INC (CORDIS)Â Â Â Â Â
5.7. EDWARDS LIFESCIENCES CORPORATION
5.8. ENDOLOGIXÂ Â Â Â Â Â Â Â Â Â
5.9. KONINKLIJKE PHILIPS NV
5.10. MEDTRONIC PLCÂ Â Â Â Â Â Â Â Â Â
5.11. TELEFLEX MEDICALÂ Â Â Â
5.12. TERUMO INTERVENTIONAL SYSTEMS INCÂ Â Â Â Â Â Â Â Â Â
6.   METHODOLOGY & SCOPE Â
6.1. RESEARCH SCOPE & DELIVERABLESÂ Â Â Â Â Â Â Â
6.2. SOURCES OF DATAÂ Â Â Â Â Â Â
6.3. RESEARCH METHODOLOGYÂ Â
TABLE 1: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF MERGER & ACQUISITIONS
TABLE 5: LIST OF PRODUCT LAUNCH & DEVELOPMENTS
TABLE 6: LIST OF PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
TABLE 7: LIST OF BUSINESS EXPANSION
TABLE 8: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2020 & 2028
FIGURE 3: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2020 & 2028
FIGURE 5: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY SELF-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2020 & 2028
FIGURE 11: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)
FIGURE 22: MIDDLE EAST AND AFRICA PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 23: UNITED ARAB EMIRATES PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: TURKEY PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: SAUDI ARABIA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: SOUTH AFRICA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: REST OF MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)